Vascularized Tumor‐on‐a‐Chip Model as a Platform for Studying Tumor‐Microenvironment‐Drug Interaction
Macromolecular Bioscience · 2025-10 · 25 (10)
DOI: 10.1002/mabi.202500240 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Macromolecular Bioscience, online erschienen am 22.07.2025. Verfasst von Hyelim Kim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, Yonsei University, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Tumor Microenvironment, Lab-On-A-Chip Devices, Neoplasms, Drug Delivery Systems. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, KIST Institutional Program, Korea-US Collaborative Research Fund.
Abstract (Originalsprache)
As cancer‐targeting technologies advance, robust platforms for evaluating drug delivery systems (DDS) under pathomimetic conditions are critically needed. Traditional models inadequately mimic human tumor microenvironment (TME) complexity due to interspecies variance, structural simplification, and static perfusion. Vascularized tumor‐on‐a‐chip systems address these gaps by integrating perfusable vasculature with tumor‐stroma dynamics in microfluidic environments, enabling dynamic 3D evaluation of drug transport kinetics and therapeutic efficacy. These advances significantly enhance preclinical‐to‐clinical translatability, though challenges remain in achieving long‐term vascular stability and multi‐tissue integration under physiological flow conditions. Herein, we summarize recent progress in vascularized tumor‐on‐a‐chip technologies for assessing DDS performance and TME interactions. Finally, opportunities for precision oncology and integrative organ‐level modeling are highlighted, underscoring the transformative potential of these platforms in next‐generation cancer research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biotechnology, Yonsei University, Seoul, Republic of Korea.
- Brain Science Institute, Korea Institute of Science and Technology (KIST), Seoul, Republic of Korea.
- Center For Nanomedicine, Institute for Basic Science (IBS), Yonsei University, Seoul, Republic of Korea.
- Division of Bio-Medical Science & Technology, KIST School, Korea University of Science and Technology (UST), Seoul, Republic of Korea.
- School of Mechanical Engineering, Yonsei University, Seoul, Republic of Korea.
- Yonsei-KIST Convergence Research Institute, Yonsei University, Seoul, Republic of Korea.
ORCID-Profile: Hong Nam Kim
Förderung
- National Research Foundation of Korea
- KIST Institutional Program
- Korea-US Collaborative Research Fund
- Ministry of Science and ICT
- Ministry of Health and Welfare
- Ministry of Food and Drug Safety
- Ministry of Science and ICT, South Korea
Zitieren
APA
Kim, H., Cho, S. W., & Kim, H. N. (2025). Vascularized Tumor‐on‐a‐Chip Model as a Platform for Studying Tumor‐Microenvironment‐Drug Interaction. Macromolecular Bioscience, 25(10). https://doi.org/10.1002/mabi.202500240
Vancouver
Kim H, Cho SW, Kim HN. Vascularized Tumor‐on‐a‐Chip Model as a Platform for Studying Tumor‐Microenvironment‐Drug Interaction. Macromolecular Bioscience. 2025;25(10). doi:10.1002/mabi.202500240
BibTeX
@article{Kim2025,
author = {Kim, Hyelim and Cho, Seung-Woo and Kim, Hong Nam},
title = {Vascularized Tumor‐on‐a‐Chip Model as a Platform for Studying Tumor‐Microenvironment‐Drug Interaction},
journal = {Macromolecular Bioscience},
year = {2025},
volume = {25},
number = {10},
doi = {10.1002/mabi.202500240}
}
EUVIMED